Double-arm Molecules Targeting CLTA-4 and CD47 may Specifically eliminate Treg Cells in Tumors and Effectively Promote Anti-tumor Immune Responses
In a new study, researchers from the University of Texas Southwestern Medical Center, Aetio Biotherapy and the Institute…
New Finding of Responses to CTLA4 Blockade in Metastatic Melanoma
Cancer immunotherapy is quite popular in recent years. From the beginning of the discoveries that our immune system can …